{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:43:05Z","timestamp":1776735785720,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"crossref","award":["2024-MN"],"award-info":[{"award-number":["2024-MN"]}],"id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"crossref","award":["2025-HH"],"award-info":[{"award-number":["2025-HH"]}],"id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02778-3","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:46:19Z","timestamp":1773377179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knockout of PAK1 and PAK4 supresses tumour growth associated with vasculogenic mimicry inhibition through EphA2\u2013VE-cadherin\u2013MCAM pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Arian","family":"Ansardamavandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Dumesny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Seng","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Nikfarjam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"23","key":"2778_CR1","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.3390\/cells12232692","volume":"12","author":"A Ansardamavandi","year":"2023","unstructured":"Ansardamavandi A, Nikfarjam M, He H. PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response. Cells. 2023;12(23):2692. https:\/\/doi.org\/10.3390\/cells12232692.","journal-title":"Cells"},{"issue":"22","key":"2778_CR2","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1200\/jco.2010.28.1386","volume":"28","author":"HL Kindler","year":"2010","unstructured":"Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O\u2019Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol. 2010;28(22):3617\u201322. https:\/\/doi.org\/10.1200\/jco.2010.28.1386.","journal-title":"J Clin Oncol"},{"key":"2778_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pharmthera.2016.01.006","volume":"159","author":"MJ Hendrix","year":"2016","unstructured":"Hendrix MJ, Seftor EA, Seftor RE, Chao JT, Chien DS, Chu YW. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma. Pharmacol Ther. 2016;159:83\u201392. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.01.006.","journal-title":"Pharmacol Ther"},{"issue":"29","key":"2778_CR4","doi-asserted-by":"publisher","first-page":"47801","DOI":"10.18632\/oncotarget.17999","volume":"8","author":"J Yang","year":"2017","unstructured":"Yang J, Zhu D-M, Zhou X-G, Yin N, Zhang Y, Zhang Z-X, Li D-C, Zhou J. HIF-2\u03b1 promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter. Oncotarget. 2017;8(29):47801. https:\/\/doi.org\/10.18632\/oncotarget.17999.","journal-title":"Oncotarget"},{"issue":"5","key":"2778_CR5","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4161\/cbt.7.5.5765","volume":"7","author":"JY Wang","year":"2008","unstructured":"Wang JY, Sun T, Zhao XL, Zhang SW, Zhang DF, Gu Q, Wang XH, Zhao N, Qie S, Sun BC. Functional significance of VEGF-a in human ovarian carcinoma: role in vasculogenic mimicry. Cancer Biol Ther. 2008;7(5):758\u201366. https:\/\/doi.org\/10.4161\/cbt.7.5.5765.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"2778_CR6","first-page":"533","volume":"21","author":"J Zhang","year":"2016","unstructured":"Zhang J, Qiao L, Liang N, Xie J, Luo H, Deng G, Zhang J. Vasculogenic mimicry and tumor metastasis. J buon. 2016;21(3):533\u201341.","journal-title":"J buon"},{"issue":"7","key":"2778_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/1354750x.2024.2415078","volume":"29","author":"DA Zinovkin","year":"2024","unstructured":"Zinovkin DA, Wang H, Yu Z, Zhang Q, Zhang Y, Wei S, Zhou T, Zhang Q, Zhang J, Nadyrov EA, Farooq A, Lyzikova Y, Vejalkin IV, Slepokurova II, Pranjol MZI. The vasculogenic mimicry, CD146(+) and CD105(+) microvessel density in the prognosis of endometrioid endometrial adenocarcinoma: a single-centre immunohistochemical study. Biomarkers. 2024;29(7):459\u201365. https:\/\/doi.org\/10.1080\/1354750x.2024.2415078.","journal-title":"Biomarkers"},{"issue":"2","key":"2778_CR8","doi-asserted-by":"publisher","first-page":"e24214","DOI":"10.1002\/jcla.24214","volume":"36","author":"X Du","year":"2022","unstructured":"Du X, Zhang Q, Wang S, Chen X, Wang Y. MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration. J Clin Lab Anal. 2022;36(2):e24214. https:\/\/doi.org\/10.1002\/jcla.24214.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"2778_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrc3645","volume":"14","author":"M Radu","year":"2014","unstructured":"Radu M, Semenova G, Kosoff R, Chernoff J. PAK signalling during the development and progression of cancer. Nat Rev Cancer. 2014;14(1):13\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"2778_CR10","doi-asserted-by":"publisher","first-page":"8357","DOI":"10.3390\/ijms26178357","volume":"26","author":"A Ansardamavandi","year":"2025","unstructured":"Ansardamavandi A, Dumesny C, Ma Y, Dong L, Ellis S, Ang C-S, Nikfarjam M, He H. P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular Normalisation. Int J Mol Sci. 2025;26(17):8357. https:\/\/doi.org\/10.3390\/ijms26178357.","journal-title":"Int J Mol Sci"},{"key":"2778_CR11","doi-asserted-by":"publisher","unstructured":"Ansardamavandi A, Dumesny C, Ma Y, Dong L, Ellis S, Ang C-S, Nikfarjam M, He H. The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer. Cancers. 2025;17(21). https:\/\/doi.org\/10.3390\/cancers17213434.","DOI":"10.3390\/cancers17213434"},{"issue":"1","key":"2778_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12964-024-01670-2","volume":"22","author":"Y Ma","year":"2024","unstructured":"Ma Y, Dumesny C, Dong L, Ang C-S, Asadi K, Zhan Y, Nikfarjam M, He H. Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity. Cell Communication Signal. 2024;22(1):287. https:\/\/doi.org\/10.1186\/s12964-024-01670-2.","journal-title":"Cell Communication Signal"},{"key":"2778_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3389\/fonc.2019.00803","volume":"9","author":"M Fern\u00e1ndez-Cort\u00e9s","year":"2019","unstructured":"Fern\u00e1ndez-Cort\u00e9s M, Delgado-Bellido D, Oliver FJ. Vasculogenic Mimicry: Become an Endothelial Cell But Not So Much. Front Oncol. 2019;9:803. https:\/\/doi.org\/10.3389\/fonc.2019.00803.","journal-title":"Front Oncol"},{"issue":"13","key":"2778_CR14","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1182\/blood.v98.13.3677","volume":"98","author":"N Bardin","year":"2001","unstructured":"Bardin N, Anfosso F, Mass\u00e9 JM, Cramer E, Sabatier F, Le Bivic A, Sampol J, Dignat-George F. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood. 2001;98(13):3677\u201384. https:\/\/doi.org\/10.1182\/blood.v98.13.3677.","journal-title":"Blood"},{"issue":"13","key":"2778_CR15","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1242\/jcs.017897","volume":"121","author":"E Dejana","year":"2008","unstructured":"Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci. 2008;121(13):2115\u201322. https:\/\/doi.org\/10.1242\/jcs.017897.","journal-title":"J Cell Sci"},{"key":"2778_CR16","doi-asserted-by":"publisher","unstructured":"Schuh JC. Trials, tribulations, and trends in tumor modeling in mice. Toxicol Pathol 32 Suppl. 2004;153\u201366. https:\/\/doi.org\/10.1080\/01926230490424770.","DOI":"10.1080\/01926230490424770"},{"issue":"2","key":"2778_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4161\/cbt.5.2.2510","volume":"5","author":"AR Hess","year":"2006","unstructured":"Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, Hendrix MJ. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther. 2006;5(2):228\u201333. https:\/\/doi.org\/10.4161\/cbt.5.2.2510.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"2778_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13402-022-00682-9","volume":"45","author":"R Zhang","year":"2022","unstructured":"Zhang R, Chen X, Chen S, Tang J, Chen F, Lin Y, Reinach PS, Yan X, Tu L, Duan H, Qu J, Hou Q. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry. Cell Oncol (Dordr). 2022;45(4):557\u201372. https:\/\/doi.org\/10.1007\/s13402-022-00682-9.","journal-title":"Cell Oncol (Dordr)"},{"issue":"10","key":"2778_CR19","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1158\/1078-0432.Ccr-11-3237","volume":"18","author":"DA Kirschmann","year":"2012","unstructured":"Kirschmann DA, Seftor EA, Hardy KM, Seftor RE, Hendrix MJ. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res. 2012;18(10):2726\u201332. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-11-3237.","journal-title":"Clin Cancer Res"},{"key":"2778_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.biochem.72.121801.161742","volume":"72","author":"GM Bokoch","year":"2003","unstructured":"Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem. 2003;72:743\u201381. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161742.","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"2778_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1042\/bc20070109","volume":"100","author":"LE Arias-Romero","year":"2008","unstructured":"Arias-Romero LE, Chernoff J. A tale of two Paks. Biol Cell. 2008;100(2):97\u2013108. https:\/\/doi.org\/10.1042\/bc20070109.","journal-title":"Biol Cell"},{"issue":"3","key":"2778_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe\u2019er J, Trent JM, Meltzer PS, Hendrix MJ. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155(3):739\u201352. https:\/\/doi.org\/10.1016\/s0002-9440(10)65173-5.","journal-title":"Am J Pathol"},{"issue":"9","key":"2778_CR23","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.7150\/jca.14120","volume":"7","author":"H Wang","year":"2016","unstructured":"Wang H, Lin H, Pan J, Mo C, Zhang F, Huang B, Wang Z, Chen X, Zhuang J, Wang D, Qiu S. Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K. J Cancer. 2016;7(9):1114\u201324. https:\/\/doi.org\/10.7150\/jca.14120.","journal-title":"J Cancer"},{"issue":"1","key":"2778_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-017-0631-x","volume":"16","author":"D Delgado-Bellido","year":"2017","unstructured":"Delgado-Bellido D, Serrano-Saenz S, Fern\u00e1ndez-Cort\u00e9s M, Oliver FJ. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer. 2017;16(1):65. https:\/\/doi.org\/10.1186\/s12943-017-0631-x.","journal-title":"Mol Cancer"},{"issue":"13","key":"2778_CR25","doi-asserted-by":"publisher","first-page":"12152","DOI":"10.1074\/jbc.M405073200","volume":"280","author":"AS Alberts","year":"2005","unstructured":"Alberts AS, Qin H, Carr HS, Frost JA. PAK1 negatively regulates the activity of the Rho exchange factor NET1. J Biol Chem. 2005;280(13):12152\u201361. https:\/\/doi.org\/10.1074\/jbc.M405073200.","journal-title":"J Biol Chem"},{"issue":"Pt 10","key":"2778_CR26","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1242\/jcs.055707","volume":"123","author":"CM Wells","year":"2010","unstructured":"Wells CM, Whale AD, Parsons M, Masters JR, Jones GE. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J Cell Sci. 2010;123(Pt 10):1663\u201373. https:\/\/doi.org\/10.1242\/jcs.055707.","journal-title":"J Cell Sci"},{"issue":"Pt 20","key":"2778_CR27","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1242\/jcs.00080","volume":"115","author":"CM Wells","year":"2002","unstructured":"Wells CM, Abo A, Ridley AJ. PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J Cell Sci. 2002;115(Pt 20):3947\u201356. https:\/\/doi.org\/10.1242\/jcs.00080.","journal-title":"J Cell Sci"},{"issue":"11","key":"2778_CR28","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1021\/acs.jmedchem.6b00638","volume":"59","author":"J Rudolph","year":"2016","unstructured":"Rudolph J, Murray LJ, Ndubaku CO, O\u2019Brien T, Blackwood E, Wang W, Aliagas I, Gazzard L, Crawford JJ, Drobnick J, Lee W, Zhao X, Hoeflich KP, Favor DA, Dong P, Zhang H, Heise CE, Oh A, Ong CC, La H, Chakravarty P, Chan C, Jakubiak D, Epler J, Ramaswamy S, Vega R, Cain G, Diaz D, Zhong Y. Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window. J Med Chem. 2016;59(11):5520\u201341. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00638.","journal-title":"J Med Chem"},{"issue":"5","key":"2778_CR29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/circresaha.118.312829","volume":"124","author":"P Binder","year":"2019","unstructured":"Binder P, Wang S, Radu M, Zin M, Collins L, Khan S, Li Y, Sekeres K, Humphreys N, Swanton E, Reid A, Pu F, Oceandy D, Guan K, Hille SS, Frey N, M\u00fcller OJ, Cartwright EJ, Chernoff J, Wang X, Liu W. Pak2 as a Novel Therapeutic Target for Cardioprotective Endoplasmic Reticulum Stress Response. Circ Res. 2019;124(5):696\u2013711. https:\/\/doi.org\/10.1161\/circresaha.118.312829.","journal-title":"Circ Res"},{"issue":"23","key":"2778_CR30","doi-asserted-by":"publisher","first-page":"15627","DOI":"10.1021\/acs.jmedchem.2c00756","volume":"65","author":"HY Chow","year":"2022","unstructured":"Chow HY, Karchugina S, Groendyke BJ, Toenjes S, Hatcher J, Donovan KA, Fischer ES, Abalakov G, Faezov B, Dunbrack R, Gray NS, Chernoff J. Development and Utility of a PAK1-Selective Degrader. J Med Chem. 2022;65(23):15627\u201341. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00756.","journal-title":"J Med Chem"},{"issue":"20","key":"2778_CR31","doi-asserted-by":"publisher","first-page":"9446","DOI":"10.1073\/pnas.0911863107","volume":"107","author":"BW Murray","year":"2010","unstructured":"Murray BW, Guo C, Piraino J, Westwick JK, Zhang C, Lamerdin J, Dagostino E, Knighton D, Loi CM, Zager M, Kraynov E, Popoff I, Christensen JG, Martinez R, Kephart SE, Marakovits J, Karlicek S, Bergqvist S, Smeal T. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc Natl Acad Sci U S A. 2010;107(20):9446\u201351. https:\/\/doi.org\/10.1073\/pnas.0911863107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2778_CR32","doi-asserted-by":"publisher","first-page":"101329","DOI":"10.1016\/j.tranon.2021.101329","volume":"16","author":"H He","year":"2022","unstructured":"He H, Dumesny C, Ang CS, Dong L, Ma Y, Zeng J, Nikfarjam M. A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabine. Transl Oncol. 2022;16:101329. https:\/\/doi.org\/10.1016\/j.tranon.2021.101329.","journal-title":"Transl Oncol"},{"key":"2778_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2019.12.020","volume":"472","author":"K Wang","year":"2020","unstructured":"Wang K, Zhan Y, Huynh N, Dumesny C, Wang X, Asadi K, Herrmann D, Timpson P, Yang Y, Walsh K, Baldwin GS, Nikfarjam M, He H. Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. Cancer Lett. 2020;472:8\u201318. https:\/\/doi.org\/10.1016\/j.canlet.2019.12.020.","journal-title":"Cancer Lett"},{"issue":"7","key":"2778_CR34","doi-asserted-by":"publisher","first-page":"e0232565","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo A, Torres Figueroa F, Clavijo C, Arbel\u00e1ez P, Cruz JC, Mu\u00f1oz-Camargo C. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS ONE. 2020;15(7):e0232565. https:\/\/doi.org\/10.1371\/journal.pone.0232565.","journal-title":"PLoS ONE"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02778-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02778-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02778-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:31:15Z","timestamp":1776735075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02778-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2778"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02778-3","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"243"}}